Catalyst Pharmaceuticals

-$0.05 (-0.75%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CPRX and other ETFs, options, and stocks.

About CPRX

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases, including Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis, spinal muscular atrophy (SMA) type 3, and infantile spasms. The company was founded by Huckel E.

CEO
Patrick J. McEnany
Employees
76
Headquarters
Coral Gables, Florida
Founded
2002

CPRX Key Statistics

Market cap
682.46M
Price-Earnings ratio
15.97
Dividend yield
—
Average volume
1.46M
High today
$6.79
Low today
$6.43
Open price
$6.72
Volume
3.76M
52 Week high
$8.65
52 Week low
$4.81

CPRX News

Simply Wall StJun 25

What Type Of Shareholders Own The Most Number of Catalyst Pharmaceuticals, Inc. Shares?

Every investor in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of youn

CPRX Earnings

$0.00
$0.05
$0.09
$0.14
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure